香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 海外監管公告 本 海 外 監 管 公 告 乃 按 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」） 第13.09條、第13.10B條及香港法例第571章《證 券 及 期 貨 條 例》第XIVA部 下 之 內 幕 消 息 條 文（定 義 見 上 市 規 則）之 規 定 作 出。 茲 載 列 該 公 告 如 下，僅 供 參 考。 承董事會命 中 國 太 平 洋 保 險（集 團）股 份 有 限 公 司 傅 帆 董事長 香 港，2025年8月29日 於 本 公 告 日 期，本 公 司 執 行 董 事 為 傅 帆 先 生 和 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 海外監管公告 本 海 外 監 管 公 告 乃 按 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」） 第13.09條、第13.10B條及香港法例第571章《證 券 及 期 貨 條 例》第XIVA部 下 之 內 幕 消 息 條 文（定 義 見 上 市 規 則）之 規 定 作 出。 茲 載 列 該 公 告 如 下，僅 供 參 考。 承董事會命 中 國 太 平 洋 保 險（集 團）股 份 有 限 公 司 傅 帆 董事長 香 港，2025年8月29日 於 本 公 告 日 期，本 公 司 執 行 董 事 為 傅 帆 先 生 和 ...

Market Performance - The Hang Seng Index opened 101 points higher on the 27th, rose 129 points to a high of 25,653 points in the early session, then fell back, and closed down 323 points or 1.3% at 25,201 points [1] - The H-shares Index fell 128 points or 1.4% to close at 9,020 points, and the Hang Seng Tech Index fell 84 points or 1.5% to close at 5,697 points [1] - The total turnover of the market increased to HK$371.376 billion, the highest in nearly four months [1] - A-share market opened slightly higher, the ChiNext Index once rose more than 2%, but all three major indices fell in the afternoon. The Shanghai Composite Index closed down 68 points or 1.8% at 3,800 points, with a turnover of RMB 1.33 trillion; the Shenzhen Component Index closed down 178 points or 1.4% at 12,295 points, with a turnover of RMB 1.84 trillion; the ChiNext Index closed down 18 points or 0.7% at 2,723 points, with a turnover of RMB 878.3 billion [2] - In the US stock market on Wednesday, the Nasdaq rose 45 points or 0.2% to 21,590 points, the S&P 500 Index rose 15 points or 0.2% to 6,481 points, and the Dow Jones Industrial Average rose 147 points or 0.3% to 45,565 points [2] Central Bank Operations - The People's Bank of China conducted RMB 379.9 billion of seven-day reverse repurchase operations on the 27th, with the operating rate remaining unchanged at 1.4%. There were RMB 616 billion of reverse repurchases maturing, resulting in a net withdrawal of RMB 236.1 billion [2] - The central parity rate of the RMB against the US dollar was raised by 80 points to 7.1108 [2] Company Earnings - Ctrip Group - S (09961.HK) reported a turnover of RMB 28.714 billion for the six months ended June this year, up 16.2% year-on-year. Net profit was RMB 9.123 billion, up 12% year-on-year, and non-GAAP net profit was also RMB 9.123 billion, up 12% year-on-year. Earnings per share were RMB 13.82. No dividend was declared [3] - Maogeping (01318.HK) reported revenue of RMB 2.588 billion for the six months ended June, up 31.3% year-on-year; gross profit was RMB 2.179 billion, up 30.2%. Net profit was RMB 670 million, up 36.1%, and earnings per share were RMB 1.37. No dividend was declared [4] - China Mengniu Dairy Company Limited (02319.HK) reported revenue of RMB 41.567 billion for the six months ended June, down 6.9% year-on-year due to the oversupply of raw milk and the slower-than-expected recovery of demand. Net profit was RMB 2.046 billion, down 16.4%, and earnings per share were 52.3 cents. No dividend was declared [4] - People's Insurance Company (Group) of China, Ltd. (01339.HK) reported total operating income of RMB 324.122 billion for the six months ended June this year, up 10.9% year-on-year. Net profit was RMB 26.671 billion, up 14% year-on-year, and earnings per share were RMB 0.6. An interim cash dividend of RMB 0.075 per 10 shares was declared, compared with RMB 0.063 per 10 shares in the same period last year [4] - Innovent Biologics, Inc. (01801.HK) reported revenue of RMB 5.953 billion for the six months ended June this year, up 50.6% year-on-year. It turned from a loss to a profit of RMB 834 million, compared with a loss of RMB 393 million in the same period last year. Earnings per share were RMB 0.51. No dividend was declared. Non-IFRS profit was RMB 1.213 billion, compared with a loss of RMB 160 million last year; non-IFRS EBITDA was RMB 1.413 billion, compared with a loss of RMB 161 million last year [5] - Meituan (03690.HK) reported a profit of RMB 365 million for the second quarter ended June 2025, down 96.8% year-on-year. Non-IFRS adjusted EBITDA was RMB 2.782 billion, down 81.5% year-on-year, and adjusted net profit fell 89% to RMB 1.493 billion. Revenue in the second quarter was RMB 91.84 billion, up 11.7% year-on-year, slightly lower than the forecast range of RMB 92.067 billion to RMB 94.534 billion by 8 brokers [5]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責 ，對其準 確性或完整性亦不發表任何聲明 ，並明確表示 ，概不對因本公告全部或任何部分內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED 炷㕤ᷕ厗Ṣ㮹ℙ⚳姣Ⅎㆸ䩳ᷳ偉ấ㚱旸℔⎠炸! 炷偉ấẋ嘇;!3739炸! 保險公司償付能力報告摘要 註 2025年第2季度 公司簡介和報告聯繫人 | 公司中文名稱： | 中國人壽保險股份有限公司 | | --- | --- | | 公司英文名稱： | China Life Insurance Company Limited | | 法定代表人： | 蔡希良 | | 註冊地址： | 中國北京市西城區金融大街16號 | | 註冊資本（營運資金）： | 人民幣282.65億元 | 註： 本 償 付 能 力 季 度 報 告 摘 要 根 據 原 中 國 銀 行 保 險 監 督 管 理 委 員 會（「原中國銀保監會 」）印 發 的《保 險 公 司 償 付 能 力監管規則（Ⅱ）》，國家金融監督管理總局（「金融監管總 ...

Group 1: Hang Seng Index (HSI) - The Hang Seng Index closed at 25,165 points, maintaining support at the middle line of the Bollinger Bands at 25,142 points, with a downward trend signal [1] - Resistance is noted at 25,491 points, while support is at 24,744 points [1] Group 2: Sunny Optical Technology (02382.HK) - Sunny Optical's stock price rose sharply, closing at HKD 82.25, marking a 9.74% increase, breaking through the upper Bollinger Band [6] - The stock is given a "strong buy" signal, with resistance levels at HKD 88.6 and HKD 89.6, indicating potential to reach HKD 90 [6] Group 3: Meituan-W (03690.HK) - Meituan's stock price is stable around HKD 120, with a "sell" signal reflecting bearish investor sentiment [12] - Support levels are at HKD 117.3 and HKD 113.1, while resistance is at HKD 125.3 [12] Group 4: Dongfang Zhenxuan (01797.HK) - Dongfang Zhenxuan's stock has shown significant volatility, closing at HKD 37.14 after reaching a high of HKD 53.7 [18] - The stock is rated as a "buy" with a slight positive outlook, and resistance is noted at HKD 47 [18] Group 5: Tencent Holdings (00700.HK) - Tencent's stock closed at HKD 590.5, with a cautious "buy" signal amid a sideways trading pattern [20] - Resistance is at HKD 608, while a bear certificate with a redemption price of HKD 610 is considered safe for investors [20] Group 6: China Life Insurance (02628.HK) - China Life's stock closed at HKD 24.62, having nearly doubled since April, indicating a long-term bullish outlook [26] - The stock is rated as a "buy," with short-term support at HKD 22.1 and a more conservative level at HKD 21.1, while resistance is at HKD 25.8 and HKD 27.1 [26]

保費收入公告 於2025年1月1日 至2025年7月31日 期 間，中 國 太 平 洋 保 險（集 團）股 份 有 限 公 司（「本公司」）子 公 司 中 國 太 平 洋 人 壽 保 險 股 份 有 限 公 司 累 計 原 保 險 保費收入為人民幣1,859.62億 元，同 比 增 長9.0%，本 公 司 子 公 司 中 國 太 平 洋財產保險股份有限公司累計原保險保費收入為人民幣1,286.28億 元， 同比增長0.8%。 上 述 累 計 原 保 險 保 費 收 入 數 據 未 經 審 計，提 請 投 資 者 注 意。 特 此 公 告。 註： 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 中 ...

Core Viewpoint - Ping An Insurance (02318) is experiencing a slight decline in stock price but shows positive developments in its property and casualty insurance claims process and steady growth in life insurance new business sales, which may support its stock price [1] Group 1: Stock Performance - As of today, Ping An's stock price is at 53.70 HKD, down 0.28%, with a previous close of 53.85 HKD, reflecting a daily decrease of 0.37% and a trading volume of 1.511 billion HKD [1] - The stock is currently in a mid-low price range, with a 55% probability of upward movement, and has shown a 6.7% fluctuation over the past five days, indicating potential for short-term volatility [3] Group 2: Technical Analysis - Multiple technical indicators suggest a "buy" signal with a strength of 10, indicating a positive medium to long-term trend [1] - The first support level is at 51.6 HKD, with a stronger support at 50.3 HKD; the initial resistance level to overcome is at 56.2 HKD, with a subsequent target of 57.4 HKD [3] Group 3: Investment Products - For investors optimistic about Ping An breaking through resistance, options include the Morgan Stanley call warrant (18269) and the Societe Generale call warrant (17282), with leverage of 8x and 7.9x, respectively [5] - For those concerned about short-term adjustments, HSBC put warrant (28259) and UBS put warrant (28275) are viable options, offering leverage of 10x and 9.6x, respectively [6] - Bullish investors may consider Morgan Stanley bull certificate (59144) with a leverage of 7.9x and a recovery price of 46.5 HKD, while bearish investors can look at Societe Generale bear certificate (51885) with a leverage of 7.5x and a recovery price of 60 HKD [7][8]

Report Summary Market Performance - Hong Kong stocks rose. The Hang Seng Index opened 38 points lower, dropped 96 points to 24,806 points in the morning, rebounded 100 points to 25,002 points before noon, and finally closed 8 points higher at 24,910 points. The H - share Index fell 18 points or 0.2% to 8,932 points, and the Hang Seng Tech Index rose 11 points or 0.2% to 5,532 points. The total turnover of the market was HK$215.235 billion [1]. - A - shares had a positive trend. The Shanghai Composite Index rose 16 points or 0.5% to 3,633 points with a turnover of RMB 707.2 billion. The Shenzhen Component Index rose 70 points or 0.6% to 11,177 points with a turnover of RMB 1.03 trillion. The ChiNext Index rose 15 points or 0.7% to 2,358 points with a turnover of RMB 521.8 billion [1]. - In the US stock market, the Nasdaq outperformed. It rose 252 points or 1.2% to 21,169 points. The S&P 500 Index rose 45 points or 0.7% to 6,345 points, and the Dow Jones Industrial Average rose 81 points or 0.2% to 44,193 points [2]. Macroeconomic News - The People's Bank of China conducted RMB 138.5 billion of seven - day reverse repurchase operations on the 6th, with an unchanged operating rate of 1.4%. There were RMB 309 billion of reverse repurchases maturing, resulting in a net withdrawal of RMB 170.5 billion. The central parity rate of the RMB against the US dollar was lowered by 43 pips to 7.1409 [1]. Company Earnings - Manulife Financial (00945.HK) reported its interim results for the six - month period ended June 30. Net income was CAD 2.274 billion, up 19.1% year - on - year and 16% at constant exchange rates. Core earnings were CAD 3.493 billion, up 1.3% year - on - year and down 2% at constant exchange rates. Earnings per share were CAD 1.23. An interim dividend of 44 cents was declared, compared with 40 cents in the same period last year [3]. - BeiGene (06160.HK) announced its Q2 results ended June 30. According to US GAAP, total revenue was USD 1.315 billion, a 42% year - on - year increase. Among them, the global revenue of Brukinsa was USD 950 million, a 49% increase. Benefiting from revenue growth and improved operating leverage, it recorded a net profit of USD 94.32 million, turning around from a loss of USD 120 million in the same period last year. Basic earnings per share were USD 0.07 [3]. Policy News - US President Trump said he might announce further tariffs on China, similar to the 25% tariff imposed on India for buying Russian oil. The specific situation would depend on future developments. Trump also announced plans to implement more secondary sanctions to force Russia to end the war in Ukraine. Last week, US Treasury Secretary Bessent warned China that it might face new tariffs if it continued to buy Russian oil [2]. - Trump said on Wednesday that the US would impose a 100% tariff on imported semiconductors and chips, but companies that moved production back to the US would be exempted [2].

Core Insights - The report highlights a stabilization in the US stock market, with investors taking advantage of lower prices, leading to a recovery in major indices [9][11] - The focus of the market has shifted towards corporate earnings and trade agreements, indicating a potential for future growth [9][11] - The report notes a significant outflow of capital from Hong Kong stocks, with net outflows reaching HKD 18.09 billion, the highest since May 12 [9][11] Market Overview - The Hang Seng Index closed at 24,733.45, up 225.64 points or 0.92%, while the Hang Seng Tech Index rose by 1.55% [15][17] - The Dow Jones Industrial Average increased by 585.06 points or 1.34%, recovering losses from previous weeks [11][15] - Notable stock performances included Tesla and Microsoft, both rising by 2.2%, while Amazon saw a decline of 1.4% [11][15] Economic Data - US factory orders decreased by 4.8% in June, marking the largest drop since 2020, aligning with expectations [11] - The report anticipates upcoming economic data releases, including the Purchasing Managers' Index for Hong Kong and China, and the Producer Price Index for the Eurozone [21] Company Recommendations - The report recommends buying shares of WuXi AppTec (2126), a leader in CAR-T cell therapy in China, with a target price of HKD 6.44 [22] - It also highlights The Southern Company (SO) for its stable cash flow and projected growth in electricity demand, making it a strong investment choice [24] - The Allstate Corporation (ALL) reported a revenue increase of 5.85% to USD 16.633 billion, with earnings per share rising significantly, indicating strong performance [25]

Core Viewpoint - China Life Insurance's stock price has shown significant volatility, currently at 22.65 HKD, down 2.37%, with various technical indicators suggesting potential upward and downward movements in the near term [2]. Technical Analysis - The stock price is currently above the 10-day moving average of 21.93 HKD, indicating a bullish formation, but the RSI at 78 suggests it is severely overbought, creating a technical divergence with sell signals from the Williams indicator [2]. - The MACD maintains a buy signal, but the shortening of the red momentum bars indicates a potential weakening of upward momentum [2]. - The Bollinger Bands are expanding, with the stock price closely following the upper band, reflecting increased short-term volatility risk, evidenced by a 10.4% 5-day amplitude [2]. - A critical support level is identified at 20.9 HKD, which combines the 30-day moving average and a psychological barrier; a breach could lead to a drop to the 18.8 HKD yearly line [2]. - The upper resistance level is at 24 HKD, and a breakthrough could challenge the previous high of 26.3 HKD [2]. - The Ichimoku Cloud shows a bullish arrangement, but the distance from the cloud indicates accumulating technical correction pressure [2]. - Divergence in momentum oscillators and sell signals from the VR ratio indicator suggest short-term adjustment risks [2]. Derivative Products Strategy - The Morley call option 28512 stands out with a leverage of 6.7 times and the lowest premium, with an exercise price set 7% below the current stock price of 20.93 HKD [5]. - The Morgan Stanley call option 29456 offers similar terms with a leverage of 6.5 times and a lower premium as an alternative [5]. - On the bearish side, the Bank of China put option 18645 is preferred for hedging downside risk, featuring a leverage of 5.1 times and the lowest premium [5]. - The Xinda put option 18677 has an exercise price of 18.28 HKD, with a leverage of 3.4 times and is 19.11% out of the money [5].